Management of Ventricular Tachycardia in Patients with Prolonged QT Interval

First-Line Treatment Options

The American Heart Association recommends lidocaine as the preferred alternative to amiodarone for ventricular tachycardia in patients with prolonged QT interval, administered at an initial dose of 1-1.5 mg/kg IV bolus, followed by maintenance infusion of 1-4 mg/min 1, 2
For patients with ventricular tachycardia and prolonged QT interval, lidocaine should be administered at an initial dose of 1-1.5 mg/kg IV bolus followed by 0.5-0.75 mg/kg IV push at 5-10 minute intervals if VT persists, with a maximum total dose of 3 mg/kg 1, 2
Maintenance infusion of lidocaine should be administered at 1-4 mg/min after successful conversion of ventricular tachycardia in patients with prolonged QT interval 1

For torsades de pointes, the American College of Cardiology recommends IV magnesium sulfate as the treatment of choice at a dose of 1-2 g diluted in 10 mL D5W 2, 5

For unstable patients with ventricular tachycardia and prolonged QT interval, the American Heart Association recommends immediate synchronized cardioversion 1, 2
For stable patients with ventricular tachycardia and prolonged QT interval, the American Heart Association recommends proceeding with pharmacological management, considering lidocaine for monomorphic VT and IV magnesium sulfate for polymorphic VT (torsades de pointes) 1, 2

The American Heart Association advises that sotalol is absolutely contraindicated in patients with prolonged QT interval as it can further prolong QT and increase the risk of torsades de pointes 1, 4
The American College of Cardiology recommends avoiding amiodarone in patients with pre-existing QT prolongation due to its potential to cause marked QT prolongation and increase the risk of torsades de pointes 4
Verapamil is contraindicated for wide-complex tachycardias unless known to be of supraventricular origin, according to the American Heart Association 3, 6

Continuous ECG monitoring is essential during and after treatment of ventricular tachycardia in patients with prolonged QT interval, as recommended by the American Academy of Family Physicians 7
Regular assessment of QT interval and electrolyte levels, particularly potassium and magnesium, is crucial in managing patients with ventricular tachycardia and prolonged QT interval 4